Upregulated lncRNA BLACAT1 was linked with aggressive breast cancer phenotype by lncRNA BLACAT1/miR-150-5p/CCR2 (C-C chemokine receptor type 2) axis (Hu et al., 2019). Here, CCR2 is linked to breast cancer.